RCKT incurs a narrower-than-expected fourth-quarter 2024 loss. The company provides updates on its pipeline candidates.
Vous n'êtes pas connecté
XENE reports a narrower-than-expected fourth-quarter 2024 loss. Its development programs for azetukalner in epilepsy and MDD are progressing well.
RCKT incurs a narrower-than-expected fourth-quarter 2024 loss. The company provides updates on its pipeline candidates.
Intellia reports better-than-expected fourth-quarter 2024 results. The company provides updates on its pipeline candidates.
KYMR reports a wider-than-expected loss for the fourth quarter of 2024. The company expects the current cash balance to provide a runway into...
BEAM incurs a narrower-than-expected loss in the fourth quarter. The company remains focused on pipeline development.
EVGO's fourth-quarter 2024 results reflect a narrower loss, 35% revenue growth YoY and a significant boost in charging network revenues.
DNLI reports a narrower-than-expected loss for the fourth quarter of 2024. Denali remains on track to submit a BLA for tividenofusp alfa for the...
Continued strength in Managed Care aids National Vision's fourth-quarter 2024 performance.
IONS reports better-than-expected top and bottom-line numbers for the fourth quarter.
AAP reports a narrower-than-expected Q4 loss and expects 2025 net sales from continuing operations in the range of $8.4-$8.6 billion.
SRPT reports mixed fourth-quarter 2024 results. It closes the multi-billion-dollar deal with Arrowhead and adds four new clinical programs to its...